Seems this paper is promotional material for the development of new inhibitors ... the research says Xantrene stacks up fine in these areas, we're in the clinic and will have results flowing from that shortly.
The good part of the paper for us is just how widely in cancer and other medicine FTO is important.
Seems this paper is promotional material for the development of...
-
- There are more pages in this discussion • 5,603 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.000(0.00%) |
Mkt cap ! $258.1M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.55 | $1.51 | $48.23K | 31.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 174 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 5523 | 1 |
View Market Depth
| Last trade - 12.18pm 23/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |